Articles
Non-Invasive Prenatal Testing (NIPT) Market Growth in Future
by PSMR Industry Web Marketing Global non invasive prenatal testing market was valued at $563.4 million in 2014, and it is expected to grow with a CAGR of 17.6% during the period 2015 - 2020. The global NIPT market is growing, due to increasing healthcare expenditure. The average maternal age is increasing in high income countries, due to changing pattern of employment, education and marriage, and increasing cost of raising a child. The increase in average maternal age is resulting in the growth of the global NIPT market. Chromosome syndromes are caused, due to chromosomal abnormalities in the humans, which is leading to genetic cause of miscarriage and congenital birth defects. According to the World Health Organization (WHO), each year approximately 3,000 to 5,000 children are born with chromosome disorder. Thus, with the increase in chromosome syndrome cases, the need for early and advance prenatal screening is increasing, which is resulting in increased demand for NIPT.Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/non-invasive-prenatal-testing-market/report-sample
The testing and
screening for fetal abnormalities has changed the women’s experience of
pregnancy. Prenatal tests are medical tests performed during the pregnancy, in
order to determine the development of fetus. However, various committees across the globe believe that the
implementation of NIPT and consequent increase in
prenatal testing would increase the incidence of abortions.
The
key companies operating in the global NIPT market include Sequenom Inc., BGI,
LifeCodexx AG, Quest Diagnostics Incorporated, Hoffmann-La Roche Ltd., Illumina
Inc., Berry Genomics Co. Ltd., Laboratory Corporation of America Holdings, and
Natera Inc.
Sponsor Ads
About PSMR Industry 
Web Marketing
44 connections, 0 recommendations, 155 honor points.Joined APSense since, March 9th, 2016, From New York, United States.
Created on Jan 16th 2018 23:45. Viewed 402 times.
